Financial reports
10-K/A
2020 FY
Annual report (amended)
13 Apr 22
10-K
2020 FY
Annual report
30 Mar 22
10-Q
2020 Q3
Quarterly report
27 Oct 21
10-Q
2020 Q2
Quarterly report
17 Sep 21
10-Q
2020 Q1
Quarterly report
3 Sep 21
10-K
2019 FY
Annual report
23 Apr 21
NT 10-Q
Notice of late quarterly filing
4 Dec 18
NT 10-Q
Notice of late quarterly filing
16 May 18
NT 10-Q
Notice of late quarterly filing
15 Nov 17
NT 10-Q
Notice of late quarterly filing
15 Aug 17
Current reports
8-K/A
Changes in Registrant's Certifying Accountant
9 Aug 21
8-K
Changes in Registrant's Certifying Accountant
5 Aug 21
8-K
Gene Biotherapeutics Announces Director Retirement
28 Jul 21
8-K
Gene Biotherapeutics Partners with Fujifilm Diosynth
26 Apr 21
8-K
Gene Biotherapeutics Secures Investment from Nostrum Pharmaceuticals, LLC
28 May 20
8-K
Gene Biotherapeutics Announces Director Retirement
20 Mar 19
8-K
Gene Biotherapeutics Announces Sale of Excellagen Technology
13 Sep 18
8-K
Taxus Cardium Announces Name
9 Jan 18
8-K
Regulation FD Disclosure
10 Jan 17
8-K
Regulation FD Disclosure
5 Jan 17
Registration and prospectus
25
Voluntary exchange delisting
13 Jan 14
424B5
Prospectus supplement for primary offering
5 Apr 13
424B5
Prospectus supplement for primary offering
13 Feb 12
424B5
Prospectus supplement for primary offering
16 Nov 11
SC TO-I/A
Issuer tender offer statement (amended)
3 Jan 11
SC TO-I/A
Issuer tender offer statement (amended)
16 Dec 10
SC TO-I
Issuer tender offer statement
2 Dec 10
424B5
Prospectus supplement for primary offering
29 Sep 10
S-3/A
Shelf registration (amended)
23 Aug 10
S-3
Shelf registration
9 Aug 10
Proxies
DEF 14A
Definitive proxy
28 May 15
DEF 14A
Definitive proxy
30 Apr 14
DEFA14A
Additional proxy soliciting materials
21 Jun 13
DEFA14A
Additional proxy soliciting materials
6 Jun 13
DEFA14A
Additional proxy soliciting materials
28 May 13
DEF 14A
Definitive proxy
29 Apr 13
PRER14A
Preliminary revised proxy
25 Apr 13
PRE 14A
Preliminary proxy
16 Apr 13
DEF 14A
Definitive proxy
24 Apr 12
DEF 14A
Definitive proxy
27 Apr 11
Other
REVOKED
Registration or securities revoked
15 Oct 24
UPLOAD
Letter from SEC
29 Apr 13
CORRESP
Correspondence with SEC
25 Apr 13
UPLOAD
Letter from SEC
25 Apr 13
UPLOAD
Letter from SEC
14 Apr 11
CORRESP
Correspondence with SEC
11 Apr 11
CORRESP
Correspondence with SEC
18 Mar 11
CORRESP
Correspondence with SEC
10 Mar 11
CORRESP
Correspondence with SEC
2 Mar 11
CORRESP
Correspondence with SEC
7 Jan 11
Ownership
SC 13G/A
Jemapete Christopher J
3 Feb 23
SC 13G/A
SABBY MANAGEMENT, LLC
5 Jan 22
SC 13G
Jemapete Christopher J
28 Apr 21
4
Christopher J Jemapete
28 Apr 21
4
Christopher J Jemapete
18 Mar 21
SC 13D/A
Jemapete Christopher J
18 Mar 21
SC 13D
Jemapete Christopher J
1 Mar 21
3
Christopher J Jemapete
1 Mar 21
SC 13G
Coluccio Christian F
22 Dec 20
3
NIRMAL MULYE
17 Aug 20